Overview
Portfolio
More
Axilium Holding
Gothenburg, Sweden
Axilium Holding invests in early‑stage technology and life‑science startups, primarily across Europe. The firm targets founders building innovative solutions in areas such as IoT, analytics, biotech, med‑devices, digital...
Portfolio
10+
Employees
<3
Founded
2018
AUM
N/A
Investment focus
Stages
Pre-Seed → Seed
Industries
Data & AnalyticsAugmented & Virtual RealityBiotechnologyDigital Health
Geographic scope
Europe
Sources
Axilium Holding
Axilium Holding invests in early‑stage technology and life‑science startups, primarily across Europe. The firm targets founders building innovative solutions in areas such as IoT, analytics, biotech, med‑devices, digital health, advanced materials and AR/VR, providing both capital and strategic support.
Portfolio
10+
Employees
<3
Founded
2018
AUM
N/A
Stages
Pre-Seed → Seed
Industries
Data & AnalyticsAugmented & Virtual RealityBiotechnologyDigital HealthInternet of Things
Geographic scope
Europe
Sources
Showing 6 of 6 matched portfolio companies
Arthur Technologies provides AI-integrated virtual office spaces that facilitate real-time collaboration and productivity for remote teams. By combining customizable 3D environments with digital co-workers, the platform enhances meeting efficiency and streamlines workflows, addressing the challenges of remote communication and team engagement.
Funding: $5.6M
Rough estimate of the amount of funding raised
Funding: $5.6M
Rough estimate of the amount of funding raised
Knodd offers a telehealth platform that connects parents with experienced pediatric healthcare professionals for remote consultations and health monitoring via video calls. This service provides timely access to child healthcare, addressing the issue of limited availability of pediatric services for families.
Funding: $3.4M
Rough estimate of the amount of funding raised
Funding: $3.4M
Rough estimate of the amount of funding raised
The startup offers a planning platform that integrates financial and operational planning tools to streamline budget processes for medium to large enterprises. By automating manual and repetitive tasks, the platform enables companies to enhance efficiency in budgeting, forecasting, and planning activities.
Funding: $2.7M
Rough estimate of the amount of funding raised
Funding: $2.7M
Rough estimate of the amount of funding raised
ResoTher Pharma develops peptide-based drugs that utilize resolution therapy to target neutrophil-driven inflammation in cardiovascular diseases. The company aims to improve patient outcomes by providing effective treatment options for conditions where inflammation is a key pathological factor.
Funding: $3.8M
Rough estimate of the amount of funding raised
Funding: $3.8M
Rough estimate of the amount of funding raised
Sarcura provides an autonomous, miniaturized device platform that automates the entire cell therapy manufacturing workflow within a compact, closed cartridge. Leveraging semiconductor chip technology, microfluidics, and machine‑learning‑driven control intelligence, the system delivers precise, cell‑level processing, real‑time quality assurance, and modular configurability for various cell therapy modalities, dramatically lowering costs and increasing production capacity for biopharma manufacturers and CDMOs.
Funding: $7.3M
Rough estimate of the amount of funding raised
Funding: $7.3M
Rough estimate of the amount of funding raised
Sigrid Therapeutics is developing SiPore21®, an orally ingested medical device designed to lower blood sugar levels in prediabetics and newly diagnosed type 2 diabetics. This gel-based solution aims to prevent the progression to type 2 diabetes, addressing the rising global prevalence of lifestyle diseases linked to poor diet and inactivity.
Showing 4 of 4 unmatched portfolio companies